I am assuming they are also responsible for the clinical trials, but I'm not sure about that. It would make sense, though, because navigating the approval processes of the different agencies requires very specialized experience and domain knowledge.
Yes, Biontech appears to be more of a long shot project aiming for a future where you can manipulate your immune system into fighting your cancer with a personalized vaccine. That's why they were in the unique position of having the skills for putting together an mRNA vaccine targeting the SARS-COV2 spike on very short notice without having established organizational knowledge of running those approval trials.
Moderna has the same setup. They just happened to be able and willing to raise huge amounts of money (and play ball with the .gov) to produce it themselves. It's also why Pfizer is claiming they can produce a billion vaccines over the next year while Moderna is only saying they can do 100 million.
usrusr|5 years ago
selectodude|5 years ago